Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

The physiological effects of transcranial electrical stimulation do not apply to parameters commonly used in studies of cognitive neuromodulation.

Parkin BL, Bhandari M, Glen JC, Walsh V.

Neuropsychologia. 2018 Apr 6. pii: S0028-3932(18)30123-4. doi: 10.1016/j.neuropsychologia.2018.03.030. [Epub ahead of print]

PMID:
29630916
2.

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.

Magenau JM, Goldstein SC, Peltier D, Soiffer RJ, Braun T, Pawarode A, Riwes MM, Kennel M, Antin JH, Cutler CS, Ho VT, Alyea EP 3rd, Parkin BL, Yanik GA, Choi SW, Lewis EC, Dinarello CA, Koreth J, Reddy P.

Blood. 2018 Mar 22;131(12):1372-1379. doi: 10.1182/blood-2017-11-815746. Epub 2018 Feb 2.

PMID:
29437593
3.

The rocky road to personalized medicine in acute myeloid leukaemia.

Brinda B, Khan I, Parkin B, Konig H.

J Cell Mol Med. 2018 Mar;22(3):1411-1427. doi: 10.1111/jcmm.13478. Epub 2018 Jan 12. Review.

4.

Gunslingers, poker players, and chickens 3: Decision making under mental performance pressure in junior elite athletes.

Parkin BL, Walsh V.

Prog Brain Res. 2017;234:339-359. doi: 10.1016/bs.pbr.2017.08.011. Epub 2017 Oct 5.

PMID:
29031471
5.

Gunslingers, poker players, and chickens 2: Decision-making under physical performance pressure in subelite athletes.

Parkin BL, Walsh V.

Prog Brain Res. 2017;234:317-338. doi: 10.1016/bs.pbr.2017.08.010. Epub 2017 Oct 5.

PMID:
29031469
6.

Gunslingers, poker players, and chickens 1: Decision making under physical performance pressure in elite athletes.

Parkin BL, Warriner K, Walsh V.

Prog Brain Res. 2017;234:291-316. doi: 10.1016/bs.pbr.2017.08.001. Epub 2017 Oct 5.

PMID:
29031468
7.

Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse.

Parkin B, Londoño-Joshi A, Kang Q, Tewari M, Rhim AD, Malek SN.

J Clin Invest. 2017 Sep 1;127(9):3484-3495. doi: 10.1172/JCI91964. Epub 2017 Aug 21.

8.

Anterior approach white line advancement: technique and long-term outcomes in the correction of blepharoptosis.

Schulz CB, Nicholson R, Penwarden A, Parkin B.

Eye (Lond). 2017 Dec;31(12):1716-1723. doi: 10.1038/eye.2017.138. Epub 2017 Aug 11.

PMID:
28799556
9.

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT.

Choi SW, Braun T, Henig I, Gatza E, Magenau J, Parkin B, Pawarode A, Riwes M, Yanik G, Dinarello CA, Reddy P.

Blood. 2017 Oct 12;130(15):1760-1767. doi: 10.1182/blood-2017-06-790469. Epub 2017 Aug 7.

10.

'Conservative' approach to periocular necrotising fasciitis with paranasal sinus involvement.

Schulz C, Ramchandani M, Parkin B.

Eur Arch Otorhinolaryngol. 2017 Sep;274(9):3549-3550. doi: 10.1007/s00405-017-4534-7. Epub 2017 Mar 24. No abstract available.

PMID:
28341964
11.

A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.

Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S.

Bone Marrow Transplant. 2017 Jan;52(1):59-65. doi: 10.1038/bmt.2016.188. Epub 2016 Jul 18.

12.

Mutant DNA quantification by digital PCR can be confounded by heating during DNA fragmentation.

Kang Q, Parkin B, Giraldez MD, Tewari M.

Biotechniques. 2016 Apr 1;60(4):175-6, 178, 180 passim. doi: 10.2144/000114401. eCollection 2016 Apr.

13.

A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.

Amin NA, Seymour E, Saiya-Cork K, Parkin B, Shedden K, Malek SN.

Clin Cancer Res. 2016 Sep 1;22(17):4525-35. doi: 10.1158/1078-0432.CCR-15-3103. Epub 2016 Apr 8.

14.

Network mechanisms of intentional learning.

Hampshire A, Hellyer PJ, Parkin B, Hiebert N, MacDonald P, Owen AM, Leech R, Rowe J.

Neuroimage. 2016 Feb 15;127:123-134. doi: 10.1016/j.neuroimage.2015.11.060. Epub 2015 Dec 4.

15.

Non-invasive Human Brain Stimulation in Cognitive Neuroscience: A Primer.

Parkin BL, Ekhtiari H, Walsh VF.

Neuron. 2015 Sep 2;87(5):932-45. doi: 10.1016/j.neuron.2015.07.032. Review.

16.

Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.

Pawarode A, Mineishi S, Reddy P, Braun TM, Khaled YA, Choi SW, Magenau JM, Harris AC, Connelly JA, Kitko CL, Parkin BL, Goldstein SC, Yanik GA, Levine JE, Ferrara JL, Couriel DR.

Biol Blood Marrow Transplant. 2016 Jan;22(1):54-60. doi: 10.1016/j.bbmt.2015.07.021. Epub 2015 Jul 26.

17.

FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.

Song Y, Magenau J, Li Y, Braun T, Chang L, Bixby D, Hanauer DA, Chughtai KA, Gatza E, Couriel D, Goldstein S, Pawarode A, Reddy P, Riwes M, Connelly J, Harris A, Kitko C, Levine J, Yanik G, Parkin B, Choi SW.

Bone Marrow Transplant. 2016 Apr;51(4):511-520. doi: 10.1038/bmt.2015.170. Epub 2015 Jul 20.

18.

Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner.

He S, Malik B, Borkin D, Miao H, Shukla S, Kempinska K, Purohit T, Wang J, Chen L, Parkin B, Malek SN, Danet-Desnoyers G, Muntean AG, Cierpicki T, Grembecka J.

Leukemia. 2016 Feb;30(2):508-13. doi: 10.1038/leu.2015.144. Epub 2015 Jun 18. No abstract available.

19.

Dynamic network mechanisms of relational integration.

Parkin BL, Hellyer PJ, Leech R, Hampshire A.

J Neurosci. 2015 May 20;35(20):7660-73. doi: 10.1523/JNEUROSCI.4956-14.2015.

20.

Long term patient-reported benefit from ptosis surgery.

Maycock N, MacGregor C, Saunders DA, Parkin B.

Eye (Lond). 2015 Jul;29(7):872-4. doi: 10.1038/eye.2015.54. Epub 2015 Apr 17.

21.

Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission.

Magenau JM, Braun T, Reddy P, Parkin B, Pawarode A, Mineishi S, Choi S, Levine J, Li Y, Yanik G, Kitko C, Churay T, Frame D, Riwes MM, Harris A, Bixby D, Couriel DR, Goldstein SC.

Ann Hematol. 2015 Jun;94(6):1033-41. doi: 10.1007/s00277-015-2349-4. Epub 2015 Mar 19.

PMID:
25784222
22.

Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia.

Parkin B, Ouillette P, Yildiz M, Saiya-Cork K, Shedden K, Malek SN.

Clin Cancer Res. 2015 May 1;21(9):2045-56. doi: 10.1158/1078-0432.CCR-14-0921. Epub 2015 Feb 4.

23.

Activating STAT6 mutations in follicular lymphoma.

Yildiz M, Li H, Bernard D, Amin NA, Ouillette P, Jones S, Saiya-Cork K, Parkin B, Jacobi K, Shedden K, Wang S, Chang AE, Kaminski MS, Malek SN.

Blood. 2015 Jan 22;125(4):668-79. doi: 10.1182/blood-2014-06-582650. Epub 2014 Nov 26.

24.

How do absorbable sutures absorb? A prospective double-blind randomized clinical study of tissue reaction to polyglactin 910 sutures in human skin.

Cartmill BT, Parham DM, Strike PW, Griffiths L, Parkin B.

Orbit. 2014 Dec;33(6):437-43. doi: 10.3109/01676830.2014.950285. Epub 2014 Sep 22.

PMID:
25244631
25.

Fractionating human intelligence.

Hampshire A, Highfield RR, Parkin BL, Owen AM.

Neuron. 2012 Dec 20;76(6):1225-37. doi: 10.1016/j.neuron.2012.06.022.

26.

Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia.

Parkin B, Ouillette P, Li Y, Keller J, Lam C, Roulston D, Li C, Shedden K, Malek SN.

Blood. 2013 Jan 10;121(2):369-77. doi: 10.1182/blood-2012-04-427039. Epub 2012 Nov 21.

27.

Assessing residual reasoning ability in overtly non-communicative patients using fMRI.

Hampshire A, Parkin BL, Cusack R, Espejo DF, Allanson J, Kamau E, Pickard JD, Owen AM.

Neuroimage Clin. 2012 Nov 30;2:174-83. doi: 10.1016/j.nicl.2012.11.008. eCollection 2012.

28.

Skin grafts in the periocular region without a bolstered dressing.

Bush K, Cartmill BT, Parkin BT.

Orbit. 2012 Feb;31(1):59-62. doi: 10.3109/01676830.2011.638096. Epub 2011 Dec 9.

PMID:
22150291
29.

Molecular pathology of gastrointestinal stromal tumors and implications for treatment and prognosis.

Parkin B, Chugh R.

Curr Probl Cancer. 2011 Sep-Oct;35(5):245-54. doi: 10.1016/j.currproblcancer.2011.10.002. No abstract available.

PMID:
22118564
30.

A pathobiological role of the insulin receptor in chronic lymphocytic leukemia.

Saiya-Cork K, Collins R, Parkin B, Ouillette P, Kuizon E, Kujawski L, Erba H, Campagnaro E, Shedden K, Kaminski M, Malek SN.

Clin Cancer Res. 2011 May 1;17(9):2679-92. doi: 10.1158/1078-0432.CCR-10-2058. Epub 2011 Feb 9.

31.

Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.

Parkin B, Erba H, Ouillette P, Roulston D, Purkayastha A, Karp J, Talpaz M, Kujawski L, Shakhan S, Li C, Shedden K, Malek SN.

Blood. 2010 Dec 2;116(23):4958-67. doi: 10.1182/blood-2010-01-266999. Epub 2010 Aug 20.

32.

NF1 inactivation in adult acute myelogenous leukemia.

Parkin B, Ouillette P, Wang Y, Liu Y, Wright W, Roulston D, Purkayastha A, Dressel A, Karp J, Bockenstedt P, Al-Zoubi A, Talpaz M, Kujawski L, Liu Y, Shedden K, Shakhan S, Li C, Erba H, Malek SN.

Clin Cancer Res. 2010 Aug 15;16(16):4135-47. doi: 10.1158/1078-0432.CCR-09-2639. Epub 2010 May 26.

33.

Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia.

Long J, Parkin B, Ouillette P, Bixby D, Shedden K, Erba H, Wang S, Malek SN.

Blood. 2010 Jul 8;116(1):71-80. doi: 10.1182/blood-2010-01-261628. Epub 2010 Apr 19.

34.

Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks.

Ouillette P, Fossum S, Parkin B, Ding L, Bockenstedt P, Al-Zoubi A, Shedden K, Malek SN.

Clin Cancer Res. 2010 Feb 1;16(3):835-47. doi: 10.1158/1078-0432.CCR-09-2534. Epub 2010 Jan 19.

35.

A new instrument for Lester Jones tube placement in conjunctivodacryocystorhinostomy.

Afshar MF, Parkin BT.

Orbit. 2009;28(6):337-8. doi: 10.3109/01676830903071224.

PMID:
19929655
36.

Medpor lower eyelid spacer: does it biointegrate?

Mavrikakis I, Francis N, Poitelea C, Parkin B, Brittain P, Olver J.

Orbit. 2009;28(1):58-62. doi: 10.1080/01676830802414855.

PMID:
19229747
37.

Optometrist referrals for cataract and "Action on Cataracts" guidelines: are optometrists following them and are they effective?

Lash SC, Prendiville CP, Samson A, Lewis K, Munneke R, Parkin BT.

Ophthalmic Physiol Opt. 2006 Sep;26(5):464-7.

PMID:
16918770
38.

Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?

Parkin B, Chew JB, White VA, Garcia-Briones G, Chhanabhai M, Rootman J.

Ophthalmology. 2005 Nov;112(11):2040-7. Epub 2005 Sep 15.

PMID:
16168486
39.

Synthesis, structure, and catalytic oxidation chemistry from the first oxo-imido Schiff base metal complexes.

Ramnauth R, Al-Juaid S, Motevalli M, Parkin BC, Sullivan AC.

Inorg Chem. 2004 Jun 28;43(13):4072-9.

PMID:
15206890
40.

Central serous chorioretinopathy and antiphospholipid antibodies--results of a pilot study.

Costen MT, Parkin BT, Davison CR, Crick MP.

Eye (Lond). 2004 Sep;18(9):938. No abstract available.

PMID:
15002021
41.

Effect of video display on the grading of diabetic retinopathy.

Costen MT, Newsom RS, Parkin B, Marsh CS, Mehta RL, Luff AJ, Canning CR.

Eye (Lond). 2004 Feb;18(2):169-74.

PMID:
14762410
42.

Pathologic quiz case: an iliac mass in a 25-year-old woman. Osteochondroma.

Parkin B, Bennett JC, Zaher A.

Arch Pathol Lab Med. 2003 Aug;127(8):e355-6. No abstract available.

PMID:
12873205
43.

Axenfeld anomaly and retinal changes in Ramon syndrome: follow-up of two sibs.

Parkin B, Law C.

Am J Med Genet. 2001 Nov 22;104(2):131-4.

PMID:
11746043
44.

A comparison of stereoscopic and monoscopic evaluation of optic disc topography using a digital optic disc stereo camera.

Parkin B, Shuttleworth G, Costen M, Davison C.

Br J Ophthalmol. 2001 Nov;85(11):1347-51.

45.

The control of matrix metalloproteinase-2 expression in normal and keratoconic corneal keratocyte cultures.

Parkin BT, Smith VA, Easty DL.

Eur J Ophthalmol. 2000 Oct-Dec;10(4):276-85.

PMID:
11192834
46.

Opacification of silicone intraocular implant requiring lens exchange.

Parkin B, Pitts-Crick M.

Eye (Lond). 2000 Oct;14 Pt 5:794-5. No abstract available.

PMID:
11116713
47.

Aspirin and warfarin therapy in oculoplastic surgery.

Parkin B, Manners R.

Br J Ophthalmol. 2000 Dec;84(12):1426-7.

48.

A clear view: the way forward for eye care on ICU. Intensive care units.

Parkin B, Cook S.

Intensive Care Med. 2000 Feb;26(2):155-6. No abstract available.

PMID:
10784301
49.

Global form perception: interactions between luminance and texture information.

van der Zwan R, Badcock DR, Parkin B.

Aust N Z J Ophthalmol. 1999 Jun-Aug;27(3-4):268-70.

PMID:
10484211
50.

Bacterial keratitis in the critically ill.

Parkin B, Turner A, Moore E, Cook S.

Br J Ophthalmol. 1997 Dec;81(12):1060-3.

Supplemental Content

Loading ...
Support Center